Arthur Arnold Distinguished Lecturer

 Janine Austin Clayton, M.D., NIH Associate Director for Research and Director of the Office of Research on Women's Health (ORWH) 

 

Janine Austin Clayton, M.D., Associate Director for Research on Women’s Health and Director of the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH), is the architect of the NIH policy requiring scientists to consider sex as a biological variable across the research spectrum. This policy is part of NIH’s initiative to enhance reproducibility through rigor and transparency. As co-chair of the NIH Working Group on Women in Biomedical Careers with NIH Director Dr. Francis Collins, Dr. Clayton also leads NIH’s efforts to advance women in science careers.

Prior to joining the ORWH, Dr. Clayton was the Deputy Clinical Director of the National Eye Institute (NEI) for seven years. A board-certified ophthalmologist, Dr. Clayton’s research interests include autoimmune ocular diseases and the role of sex and gender in health and disease. She is the author of more than 80 scientific publications, journal articles, and book chapters.

Dr. Clayton, a native Washingtonian, received her undergraduate degree with honors from Johns Hopkins University and her medical degree from Howard University College of Medicine. She completed a residency in ophthalmology at the Medical College of Virginia. Dr. Clayton completed fellowship training in cornea and external disease at the Wilmer Eye Institute at Johns Hopkins Hospital and in uveitis and ocular immunology at NEI.

Dr. Clayton has received numerous awards, including the Senior Achievement Award from the Board of Trustees of the American Academy of Ophthalmology in 2008 and the European Uveitis Patient Interest Association Clinical Uveitis Research Award in 2010. She was selected as a 2010 Silver Fellow by the Association for Research in Vision and Ophthalmology. In 2015, she was awarded the American Medical Women’s Association Lila A. Wallis Women’s Health Award and the Wenger Award for Excellence in Public Service. Dr. Clayton was granted the Bernadine Healy Award for Visionary Leadership in Women’s Health in 2016. She was also selected as an honoree for the Woman’s Day Red Dress Awards and the American Medical Association’s Dr. Nathan Davis Awards for Outstanding Government Service in 2017.

 

Capstone Speaker

Dr. Roberta Brinton Director, UA Center for Innovation in Brain Science, University of Arizona Health Sciences

 

Dr. Roberta Diaz Brinton leads the Center for Innovation in Brain Science at the University of Arizona. She is an internationally recognized expert on sex differences in the aging brain and women and their risk of Alzheimer’s disease. Her scientific discoveries have led to the development of innovative therapeutics to prevent, delay and treat Alzheimer’s disease. Brinton is developing the first regenerative therapeutic to regenerate the degenerated brain.

Dr. Brinton earned her Ph.D. as an NIH Predoctoral Fellow at the University of Arizona and went on to Rockefeller University as an NIH Postdoctoral Fellow. Brinton is a Regents Professor of Pharmacology, Neuroscience and Neurology at the UArizona College of Medicine – Tucson.

Brinton serves on the Alzheimer’s Drug Discovery Foundation (ADDF) Board of Governors and the National Institutes of Health scientific boards and panels. Her research is funded by the National Institute on Aging, Alzheimer’s Drug Discovery Foundation, Alzheimer’s Association and the Women’s Alzheimer’s Movement (WAM).

Her honors include the ADDF Scientist of the Year, the Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery and the 2010 U.S. Presidential Citizens Medal, the highest civilian honor for her work in improving science and technology education for underprivileged students.

 

OSSD is proud to present a special symposium featuring Dr. Sabra Klein

COVID-19 Special Session: Sex and gender differences in COVID-19

Chair: Dr. Sabra Klein, Johns Hopkins Bloomberg School of Public Health

Dr. Sabra Klein, Johns Hopkins Bloomberg School of Public Health
Sex differences in COVID-19 from hamsters to humans 

Dr. Eileen Scully, Johns Hopkins University School of Medicine
The clinical spectrum of COVID-19: sex, gender and disease susceptibility

Dr. Rosemary Morgan, Johns Hopkins Bloomberg School of Public Health
The gendered impacts of COVID-19 and the need for a gender responsive pandemic plan